Sage Therapeutics Aktie

6,46 EUR -0,23 EUR -3,38 %

14:03:52

STU

7,21 USD -0,17 USD -2,24 %

16:03:05

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.409,98 Mio. EUR

Div. Rendite0,00%

WKNA117WF

ISINUS78667J1088

SymbolSAGE

Sage Therapeutics Aktien News

Sortieren:Datum Meistgelesen

10.10.24PR NewswireSage Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - SAGE

09.10.24PR NewswireSAGE INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In XXX To Contact Him Directly To Discuss Their Options

07.10.24ZacksSage Therapeutics Stock Down Almost 40% in 3 Months: Here's Why

04.10.24BenzingaThe Analyst Verdict: Sage Therapeutics In The Eyes Of 13 Experts

03.10.24PR NewswireSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit

30.09.24PR NewswireThe Gross Law Firm Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE

26.09.24BenzingaBiogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate

25.09.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE

17.09.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE

16.09.24PR NewswireSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit

11.09.24PR NewswireSage Potash Shares to Resume Trading

10.09.24PR NewswireCanadian Investment Regulatory Organization Trade Resumption - SAGE

10.09.24PR NewswireSAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

09.09.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE

09.09.24PR NewswireCanadian Investment Regulatory Organization Trading Halt - SAGE

09.09.24PR NewswireSage Potash Announces Equipment Purchase and Financing

05.09.24PR NewswireSage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE

03.09.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE

02.09.24PR NewswireSAGE SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

02.09.24Lang & Schwarz TradeCenter AG & Co. KGDiese 10 europäischen Tech-Aktien könnten im 2. Halbjahr so richtig durchstarten

30.08.24ZacksSage Therapeutics (SAGE) Down 17.1% Since Last Earnings Report: Can It Rebound?

09.08.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

03.08.24finanzen.netSage Therapeutics stellte das Zahlenwerk zum vergangenen Quartal vor

01.08.24ZacksSage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise

31.07.24ZacksSage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Tops Revenue Estimates

30.07.24BenzingaExpert Outlook: Sage Therapeutics Through The Eyes Of 14 Analysts

30.07.24finanzen.netAusblick: Sage Therapeutics zieht Bilanz zum jüngsten Jahresviertel

26.07.24ZacksThe Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical

25.07.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

24.07.24ZacksSage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

26.06.24PR NewswireSAGE POTASH ANNOUNCES APPOINTMENTS OF A NEW BOARD OF DIRECTORS MEMBER, STRATEGIC OPERATIONS PARTNER AND GLOBAL FINANCE & TRADE PARTNER

Sage Therapeutics News

Sage Therapeutics News: auf dieser Seite finden Sie alle Sage Therapeutics News und Nachrichten zur Sage Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sage Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sage Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.